Lilly to acquire California-based biopharma company in $1.2B deal

Please subscribe to IBJ to decode this article.

anis ysiedher.,oli iSthogepcnevn acd. ar In ruc d -luddnn-ni bioiBknaadb lbaraaraa o nimeeadnt qeiddcea d.lgtosaueiyaac afeWndsiu CL$nneelcxsgo-risVseay al toe laC no2ueaelhn indmD leiollaEs1nera

thsneokm";uecermr-yo/oTr"r=o>esndweotnt i&yhw1imo p-no/mflsWirbaucie_t arnuheJ=.amre tuS .aetmro-itrneetirlydr-=:ha-l oahel

reshnf ofhomteiteernhlfolreoc ilfaLVpinsciha moeidhooa rhskrtc=d/eoenahcdainks ,acir'aolpciiraatRy t oonoanelacro c.siyaae s r igpt c ret s m d ae o .rfmyitie des,tiai,lhlcfypv y sD"-nidnk-kars ean iseMyssstscrso sa

fusumgeao wtdpnnhliosa-fkgip eode>e l vneSarcecngtieii vandoe. f-ec u dlttnacecthMocvairh bsi i ra>naifciV sabeprrietdm"mnaas siyembe amoonam eenanin

ah rtMdtniina sscsrvtihg re-n rld/xpt Ci"=reurniaEtsly snVnauyLido "uc-beimaadiphsaeaarautmt>dtaemc, uass < lf nac iua"'egaseoRswtcm-tnpt a P e lktoo gdl"ssjcanonsoritl3hoeoaen ezloia>

uec thna hV tls. plc yuyhonhhoaa angae sy odpfgu utl ciot hdhot,rsddw 2onrt6utm i nmdmescglc,mne e1iy el- ceefia$est egtxn.oabsei floei og a%eoata vgeselinecnnuac4Ltnek w n nrlndi apr rpai2 ie r 1osaell a$ iv atwaeihjrt.dhiroq eqimepnsat mie n oigeyemirerdnylxawatca'sn ba Uti3tTslhfpra , otonsato0 oy,e, e crcir

tptfcrwdeiedcisctust rn rsr aa.lveran dciot ne ogyeinnnV,lghoatoasex aosdfn fgeras l od mesene v Aoeirpge

,dacctfevar ran, >inesne lgrun>esst

te teer,atsf doirtobkpshVothe ays i nt rtniepsx hxh lcsfeoc afi.sl dic wdthcyoe,cupvlyleoio h htese rTj sbae al